Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 20–20 | Cite as

Evaluating acalabrutinib in mantle cell lymphoma

Meeting report

Reference

  1. Alrawashdh N, et al. Economic Evaluation for the US of Ibrutinib Versus Acalabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma. 60th Annual Meeting and Exposition of the American Society of Hematology : abstr. 4829, 1 Dec 2018. Available from: URL: https://ash.confex.com/ash/2018/webprogram/Paper112619.html

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations